2016
DOI: 10.1371/journal.pone.0149201
|View full text |Cite
|
Sign up to set email alerts
|

Cytoskeletal Linker Protein Dystonin Is Not Critical to Terminal Oligodendrocyte Differentiation or CNS Myelination

Abstract: Oligodendrocyte differentiation and central nervous system myelination require massive reorganization of the oligodendrocyte cytoskeleton. Loss of specific actin- and tubulin-organizing factors can lead to impaired morphological and/or molecular differentiation of oligodendrocytes, resulting in a subsequent loss of myelination. Dystonin is a cytoskeletal linker protein with both actin- and tubulin-binding domains. Loss of function of this protein results in a sensory neuropathy called Hereditary Sensory Autono… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 46 publications
0
5
0
Order By: Relevance
“…It is interesting to note that, in terms of actin dynamics, the process of axonal sorting by Schwann cells could actually be considered equivalent to oligodendrocytes branching and their initial ensheathment of axons (Feltri et al, 2016). Hence, supported by studies of several other regulators of actin dynamics, such as Myosin II (Wang et al, 2008), Dynamin 2 (Gerber et al, 2019), and Dystonin I (Kornfeld et al, 2016), our findings indicate the existence of fundamental differences in the role actin reorganization plays during CNS and PNS myelination. Alternatively, the relative limited effect N-Wasp ablation has on CNS compared with PNS myelination could result from a possible compensatory mechanism by other actin nucleation-promoting factors of the Arp2/3 complex.…”
Section: Discussionmentioning
confidence: 99%
“…It is interesting to note that, in terms of actin dynamics, the process of axonal sorting by Schwann cells could actually be considered equivalent to oligodendrocytes branching and their initial ensheathment of axons (Feltri et al, 2016). Hence, supported by studies of several other regulators of actin dynamics, such as Myosin II (Wang et al, 2008), Dynamin 2 (Gerber et al, 2019), and Dystonin I (Kornfeld et al, 2016), our findings indicate the existence of fundamental differences in the role actin reorganization plays during CNS and PNS myelination. Alternatively, the relative limited effect N-Wasp ablation has on CNS compared with PNS myelination could result from a possible compensatory mechanism by other actin nucleation-promoting factors of the Arp2/3 complex.…”
Section: Discussionmentioning
confidence: 99%
“…Dystonin is a cytoskeletal crosslinker protein that binds to actin and tubulin. This protein dysfunction can lead to sensory neuropathy, known as the human muscle-atrophic sensory autonomic neuropathy [28]. According to our research, this is the first time that dystonin and synovium pain in KOA have correlated.…”
Section: Discussionmentioning
confidence: 94%
“…We also assessed whether It is likely that the ENS contains other compensatory spectraplakin proteins (eg, Macf1) that make up for dystonin loss-of-function, which has been suggested for other cell types that express dystonin but do not exhibit defects or cell death. 5,[42][43][44] Nevertheless, Dst dt-27J mice do exhibit a small reduction in GI motility as well as a thinning of the mucous layer lining the colon. We believe that these effects are linked to dystonin loss-of-function impacting the extrinsic neural input on the ENS.…”
Section: Discussionmentioning
confidence: 98%
“…Our recent findings related to Dst ‐ a3 upregulation and compensation in dystonin‐dependent tissues would also suggest that the lack of any increase in Dst‐a/b3 expression at any GIT level in Dst dt‐Tg4 mice might indicate that the enteric nervous system is not impacted by dystonin loss‐of‐function (Figure S3). It is likely that the ENS contains other compensatory spectraplakin proteins (eg, Macf1) that make up for dystonin loss‐of‐function, which has been suggested for other cell types that express dystonin but do not exhibit defects or cell death …”
Section: Discussionmentioning
confidence: 99%